{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-164198","form_type":"8-K","ticker":"ALDX","cik":"0001341235","company_name":"Aldeyra Therapeutics, Inc.","filed_at":"2026-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.173777+00:00","generated_at":"2026-05-15T05:17:31.220288+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Director Martin J. Joyce will not stand for re-election at 2026 annual meeting","bullets":["Martin J. Joyce notified Aldeyra on April 20, 2026 of his decision not to stand for re-election.","His term will expire at the upcoming 2026 annual meeting of stockholders.","The decision was not the result of any disagreement with Aldeyra."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-164198","json":"https://secwatch.observer/filing/0001193125-26-164198.json","markdown":"https://secwatch.observer/filing/0001193125-26-164198.md","text":"https://secwatch.observer/filing/0001193125-26-164198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526164198/0001193125-26-164198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526164198/aldx-20260420.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:17:31.220288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}